Michael Bader

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2020-11-19

Top Assignees for applications by Michael Bader

The entities that hold a legal rights for patent applications filed by inventor Bader Michael:

MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN 3 Berlin, Germany
FORSCHUNGSVERBUND BERLIN E.V. 3 Berlin, Germany
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN 2 BERLIN, Germany
UNIVERSIDADE FEDERAL DE MINAS GERAIS 1 Belo Horizonte, Brazil
ARTEMIS PHARMACEUTICALS GMBH 1 KOLN, Germany
Max-Delbruck-Centrum fur Molekularc Medizin 1 , Germany
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT 1 Berlin, Germany
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN BERLIN-BUCH 1 BERLIN, Germany

Recent patent applications by Bader Michael

Michael Bader from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-11-19

US20200360258A1

Human necessities

Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation

#2 | 2020-08-20

US20200262847A1

Chemistry; metallurgy

Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same

#3 | 2019-05-30

US20190161503A1

Chemistry; metallurgy

Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same

#4 | 2018-02-22

US20180051025A1

Chemistry; metallurgy

Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same

#5 | 2014-01-30

US20140031411A1

Chemistry; metallurgy

GPNMB/OSTEOACTIVIN AS A BIOMARKER AND DRUG TARGET IN CARDIAC DISEASES

#6 | 2009-09-03

US20090221498A1

Human necessities

Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists

#7 | 2009-01-22

US20090025097A1

Chemistry; metallurgy

SHRNA AND SIRNA AND MIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE

#8 | 2007-12-27

US20070299128A1

Human necessities

Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing Tumors

#9 | 2006-12-07

US20060275759A1

Chemistry; metallurgy

Neuronally expressed tryptophane hydroxylase and its use

#10 | 2006-05-23

US10363474

Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency

InventorID:

632728 ⎘